Bioxytran (BIXT) Earnings Date, Estimates & Call Transcripts → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free BIXT Stock Alerts $0.12 0.00 (0.00%) (As of 04/18/2024 ET) Add Compare Share Share EarningsStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Earnings SummaryLatest Earnings DateMar. 22EstimatedActual EPS (Mar. 22) -$0.01 Missed By -$0.01 Get Bioxytran Earnings AlertsEnter your email address below to receive the latest news and earnings results for BIXT and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueBIXT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BIXT Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad DTIBiden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story BIXT Earnings Date and InformationBioxytran last released its quarterly earnings results on March 22nd, 2024. The reported ($0.01) EPS for the quarter. Bioxytran has generated ($0.04) earnings per share over the last year (($0.04) diluted earnings per share). Read More Bioxytran Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript3/22/2024Q4 2023-($0.01)($0.01)($0.01)--11/2/2023Q3 2023-($0.01)($0.01)($0.01)--7/31/2023Q2 2023-($0.01)($0.01)($0.01)--5/12/2023Q1 2023-($0.01)($0.01)($0.01)--8/15/2022Q2 2022-($0.01)($0.01)($0.01)--5/23/2022Q1 2022-($0.01)($0.01)($0.01)-- Get the Latest News and Ratings for BIXT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bioxytran and its competitors with MarketBeat's FREE daily newsletter. 4/11/2022Q4 2021-($0.01)($0.01)($0.01)--8/10/2021Q2 2021-($0.01)($0.01)($0.01)--5/17/2021Q1 2021-($0.02)($0.02)($0.02)-- Bioxytran Earnings - Frequently Asked Questions When did Bioxytran announce their last quarterly earnings? Bioxytran (OTCMKTS:BIXT) last announced its quarterly earning data on Friday, March 22, 2024. Learn more on BIXT's earnings history. How much profit does Bioxytran generate each year? Bioxytran (OTCMKTS:BIXT) has a recorded net income of -$4.28 million. BIXT has generated -$0.04 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: Lumos Pharma Earnings Biora Therapeutics Earnings Allarity Therapeutics Earnings Indaptus Therapeutics Earnings Synlogic Earnings Onconova Therapeutics Earnings KALA BIO Earnings Vincerx Pharma Earnings Talphera Earnings Sol-Gel Technologies Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later?Is Roku worth a second look after the earnings panic selloff? This page (OTCMKTS:BIXT) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 MediaThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIBiden replacement revealed?Paradigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchHow Biden has already won 2024Porter & CompanyOptions trading has suddenly become more reliable.Eagle Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioxytran, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.